Language: Spanish
References: 107
Page: 16-25
PDF size: 199.98 Kb.

Text Extraction

No abstract

REFERENCES

1. Cherney DL, Amstutz HC: Total hip replacement in the previously septic hip. J Bone Joint Surg Am. 1983; 65(9): 1256-1265.

2. Jupiter JB, Karchmer AW, Lowell JD, Harris WH: Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis. J Bone Joint Surg Am. 1981; 63(2): 194-200.

3. Cruess RL, Bickel WS, vonKessler KL: Infections in total hips secondary to a primary source elsewhere. Clin Orthop Relat Res. 1975; (106): 99-101.

4. Del Sel HJ, Charnley J: Total hip replacement following infection in the opposite hip. Clin Orthop Relat Res. 1979; (141): 138-142.

5. Fitzgerald RH Jr, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA 2nd, Coventry MB: Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. 1977; 59(7): 847-855.

6. Hanssen AD, Rand JA: Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect. 1999; 48: 111-122.

7. Schmalzried TP, Amstutz HC, Au MK, Dorey FJ: Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin Orthop Relat Res. 1992; (280): 200-207.

8. Stinchfield FE, Bigliani LU, Neu HC, Goss TP, Foster CR: Late hematogenous infection of total joint replacement. J Bone Joint Surg Am. 1980; 62(8): 1345-1350.

9. Thomas BJ, Moreland JR, Amstutz HC: Infection after total joint arthroplasty from distal extremity sepsis. Clin Orthop Relat Res. 1983; (181): 121-125.

10. Hanssen AD, Osmon DR, Nelson CL: Prevention of deep periprosthetic joint infection. Instr Course Lect. 1997; 46: 555-567.

11. Peersman G, Laskin R, Davis J, Peterson M: Infection in total knee replacement: a retrospective review of 6,489 total knee replacements. Clin Orthop Relat Res. 2001; (392): 15-23.

12. American Diabetes Association: Standards of medical care in diabetes-2013. Diabetes Care. 2013; 36(Suppl 1): S11-66.

13. Jamsen E, Nevalainen P, Kalliovalkama J, Moilanen T: Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010; 21(3): 196-201.

14. Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP: The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009; 91(7): 1621-1629.

15. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al: Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998; 22(2): 77-81.

16. Adams AL, Paxton EW, Wang JQ, et al: Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am. 2013; 95(6): 481-487.

17. Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL: Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012; 27(5): 726-729.

18. Del Savio GC, Zelicof SB, Wexler LM, et al: Preoperative nutritional status and outcome of elective total hip replacement. Clin Orthop Relat Res. 1996; (326): 153-161.

19. Gherini S, Vaughn BK, Lombardi AV Jr, Mallory TH: Delayed wound healing and nutritional deficiencies after total hip arthroplasty. Clin Orthop Relat Res. 1993; (293): 188-195.

20. Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J: Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res. 2008; 466(6): 1368-1371.

21. Lavernia CJ, Sierra RJ, Baerga L: Nutritional parameters and short term outcome in arthroplasty. J Am Coll Nutr. 1999; 18(3): 274-278.

22. Nicholson JA, Dowrick AS, Liew SM: Nutritional status and short-term outcome of hip arthroplasty. J Orthop Surg (Hong Kong). 2012; 20(3): 331-335.

23. Jensen JE, Jensen TG, Smith TK, Johnston DA, Dudrick SJ: Nutrition in orthopaedic surgery. J Bone Joint Surg Am. 1982; 64(9): 1263-1272.

24. Fletcher RH, Fairfield KM: Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002; 287(23): 3127-3129.

25. Flegal KM, Carroll MD, Kit BK, Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012; 307(5): 491-497.

26. Chen J, Cui Y, Li X, et al: Risk factors for deep infection after total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg. 2013; 133(5): 675-687.

27. Dowsey MM, Choong PF: Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res. 2009; 467(6): 1577-1581.

28. Everhart JS, Altneu E, Calhoun JH: Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty. Clin Orthop Relat Res. 2013. Epub before print.

29. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE: Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty. 2009; 24(Suppl 6): 84-88.

30. Jibodh SR, Gurkan I, Wenz JF: In-hospital outcome and resource use in hip arthroplasty: influence of body mass. Orthopedics. 2004; 27(6): 594-601.

31. Peersman G, Laskin R, Davis J, Peterson MG, Richart T: Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J. 2006; 2(1): 70-72.

32. McElroy MJ, Pivec R, Issa K, Harwin SF, Mont MA: The effects of obesity and morbid obesity on outcomes in TKA. J Knee Surg. 2013; 26(2): 83-88.

33. Freeman JT, Anderson DJ, Hartwig MG, Sexton DJ: Surgical site infections following bariatric surgery in community hospitals: a weighty concern? Obes Surg. 2011; 21(7): 836-840.

34. Singh JA, Houston TK, Ponce BA, et al: Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans. Arthritis Care Res (Hoboken). 2011; 63(10): 1365-1374.

35. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO: Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med. 2011; 124(2): 144-154.

36. Myers K, Hajek P, Hinds C, McRobbie H: Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med. 2011; 171(11): 983-989.

37. Sorensen LT: Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012; 147(4): 373-383.

38. Sorensen LT, Karlsmark T, Gottrup F: Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003; 238(1): 1-5.

39. Sadr Azodi O, Bellocco R, Eriksson K, Adami J: The impact of tobacco use and body mass index on the length of stay in hospital and the risk of post-operative complications among patients undergoing total hip replacement. J Bone Joint Surg Br. 2006; 88(10): 1316-1320.

40. Lindstrom D, Sadr Azodi O, Wladis A, et al: Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg. 2008; 248(5): 739-745.

41. Harris AH, Reeder R, Ellerbe L, Bradley KA, Rubinsky AD, Giori NJ: Preoperative alcohol screening scores: association with complications in men undergoing total joint arthroplasty. J Bone Joint Surg Am. 2011; 93(4): 321-327.

42. Bradley KA, Rubinsky AD, Sun H, et al: Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med. 2011; 26(2): 162-169.

43. Tonnesen H, Rosenberg J, Nielsen HJ, et al: Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999; 318(7194): 1311-1316.

44. Sunday JM, Guille JT, Torg JS: Complications of joint arthroplasty in patients with end-stage renal disease on hemodialysis. Clin Orthop Relat Res. 2002; (397): 350-355.

45. Lieberman JR, Fuchs MD, Haas SB, et al: Hip arthroplasty in patients with chronic renal failure. J Arthroplasty. 1995; 10(2): 191-195.

46. Sakalkale DP, Hozack WJ, Rothman RH: Total hip arthroplasty in patients on long-term renal dialysis. J Arthroplasty. 1999; 14(5): 571-575.

47. Pour AE, Matar WY, Jafari SM, Purtill JJ, Austin MS, Parvizi J: Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am. 2011; 93(15): 1448-1454.

48. Hsieh PH, Chen LH, Lee MS, Chen CH, Yang WE, Shih CH: Hip arthroplasty in patients with cirrhosis of the liver. J Bone Joint Surg Br. 2003; 85(6): 818-821.

49. Cohen SM, Te HS, Levitsky J: Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty. 2005; 20(4): 460-466.

50. Berbari EF, Osmon DR, Lahr B, et al: The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol. 2012; 33(8): 774-781.

51. Guichelaar MM, Schmoll J, Malinchoc M, Hay JE: Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology. 2007; 46(4): 1198-1207.

52. Ramsey-Goldman R, Dunn JE, Dunlop DD, et al: Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res. 1999; 14(3): 456-463.

53. Tannenbaum DA, Matthews LS, Grady-Benson JC: Infection around joint replacements in patients who have a renal or liver transplantation. J Bone Joint Surg Am. 1997; 79(1): 36-43.

54. Lehman CR, Ries MD, Paiement GD, Davidson AB: Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty. 2001; 16(3): 330-335.

55. Habermann B, Eberhardt C, Kurth AA: Total joint replacement in HIV positive patients. J Infect. 2008; 57(1): 41-46.

56. Hicks JL, Ribbans WJ, Buzzard B, et al: Infected joint replacements in HIV-positive patients with haemophilia. J Bone Joint Surg Br. 2001; 83(7): 1050-1054.

57. Lee J, Singletary R, Schmader K, Anderson DJ, Bolognesi M, Kaye KS: Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am. 2006; 88(8): 1705-1712.

58. Jamsen E, Huhtala H, Puolakka T, Moilanen T: Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am. 2009; 91(1): 38-47.

59. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J: Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010; 468(1): 52-56.

60. Willis-Owen CA, Konyves A, Martin DK: Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5,277 cases. J Bone Joint Surg Br. 2010; 92(8): 1128-1133.

61. Dye BA, Tan S, Smith V, et al: Trends in oral health status: United States, 1988-1994 and 1999-2004. Vital Health Stat 11. 2007; (248): 1-92.

62. Bartzokas CA, Johnson R, Jane M, Martin MV, Pearce PK, Saw Y: Relation between mouth and haematogenous infection in total joint replacements. BMJ. 1994; 309(6953): 506-508.

63. Barrington JW, Barrington TA: What is the true incidence of dental pathology in the total joint arthroplasty population? J Arthroplasty. 2011; 26(Suppl 6): 88-91.

64. LaPorte DM, Waldman BJ, Mont MA, Hungerford DS: Infections associated with dental procedures in total hip arthroplasty. J Bone Joint Surg Br. 1999; 81(1): 56-59.

65. Sandhu SS, Lowry JC, Morton ME, Reuben SF: Antibiotic prophylaxis, dental treatment and arthroplasty: time to explode a myth. J Bone Joint Surg Br. 1997; 79(4): 521-522.

66. Parvizi J, Della Valle CJ: AAOS Clinical Practice Guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg. 2010; 18(12): 771-772.

67. Perl TM, Golub JE: New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother. 1998; 32(1): S7-16.

68. Kenner J, O’Connor T, Piantanida N, et al: Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol. 2003; 24(6): 439-444.

69. Schwarzkopf R, Takemoto RC, Immerman I, Slover JD, Bosco JA: Prevalence of Staphylococcus aureus colonization in orthopaedic surgeons and their patients: a prospective cohort controlled study. J Bone Joint Surg Am. 2010; 92(9): 1815-1819.

70. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA: Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000; 21(5): 319-323.

71. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR: Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res. 2008; 466(6): 1349-1355.

72. Schweizer M, Perencevich E, McDanel J, et al: Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ. 2013; 346: f2743.

73. Kallen AJ, Wilson CT, Larson RJ: Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol. 2005; 26(12): 916-922.

74. Van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA: Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother. 2008; 61(2): 254-261.

75. Johnson AJ, Daley JA, Zywiel MG, Delanois RE, Mont MA: Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty. 2010; 25(Suppl 6): 98-102.

76. Cox RA, Conquest C: Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1997; 35(2): 117-127.

77. Muder RR, Brennen C, Goetz AM: Infection with methicillin-resistant Staphylococcus aureus among hospital employees. Infect Control Hosp Epidemiol. 1993; 14(10): 576-578.

78. Simmons BP, Munn C, Gelfand M: Toxic shock in a hospital employee due to methicillin-resistant Staphylococcus aureus. Infect Control. 1986; 7(7): 350.

79. Dutch Working Party for Infection Prevention: MRSA in nursing homes [Internet]. 2007 [Accessed 2013]. Available in: www.wip.nl.

80. Garner JS: Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol. 1996; 17(1): 53-80.

81. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI: Empfehlung zur prävention und kontrolle von methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitbsbl-Gesundheitsforsch-Geseun-dheitsschutz. 1999; 42: 954-956.

82. Bowler I: Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1997; 36(4): 321-322.

83. Lessing MP, Jordens JZ, Bowler IC: When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect. 1996; 34(3): 205-210.

84. Koulouvaris P, Sculco P, Finerty E, Sculco T, Sharrock NE: Relationship between perioperative urinary tract infection and deep infection after joint arthroplasty. Clin Orthop Relat Res. 2009; 467(7): 1859-1867.

85. Ollivere BJ, Ellahee N, Logan K, Miller-Jones JC, Allen PW: Asymptomatic urinary tract colonization predisposes to superficial wound infection in elective orthopaedic surgery. Int Orthop. 2009; 33(3): 847-850.

86. Lawrence VA, Gafni A, Gross M: The unproven utility of the preoperative urinalysis: economic evaluation. J Clin Epidemiol. 1989; 42(12): 1185-1192.

87. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM: Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005; 40(5): 643-654.

88. Rajamanickam A, Noor S, Usmani A: Should an asymptomatic patient with an abnormal urinalysis (bacteriuria or pyuria) be treated with antibiotics prior to major joint replacement surgery? Cleve Clin J Med. 2007; 74(Suppl 1): S17-18.

89. Bozic KJ, Lau E, Kurtz S, et al: Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012; 94(9): 794-800.

90. Schrama JC, Espehaug B, Hallan G, et al: Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken). 2010; 62(4): 473-479.

91. Howe CR, Gardner GC, Kadel NJ: Perioperative medication management for the patient with rheumatoid arthritis. J Am Acad Orthop Surg. 2006; 14(9): 544-551.

92. Jain A, Maini R, Nanchahal J: Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data. Ann Rheum Dis. 2004; 63(5): 602-603.

93. Giles JT, Bartlett SJ, Gelber AC, et al: Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum. 2006; 55(2): 333-337.

94. Momohara S, Kawakami K, Iwamoto T, et al: Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011; 21(5): 469-475.

95. Grennan DM, Gray J, Loudon J, Fear S: Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001; 60(3): 214-217.

96. Perhala RS, Wilke WS, Clough JD, Segal AM: Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum. 1991; 34(2): 146-152.

97. Carpenter MT, West SG, Vogelgesang SA, Casey-Jones DE: Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics. 1996; 19(3): 207-210.

98. Health Canada Drug Product Database [Internet]. 2013 [accessed May 28, 2013]. Available from: http://hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index-eng.php.

99. Le Dantec L, Maury F, Flipo RM, et al: Peripheral pyogenic arthritis. A study of one hundred seventy-nine cases. Rev Rhum Engl Ed. 1996; 63(2): 103-110.

100. Morgan DS, Fisher D, Merianos A, Currie BJ: An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect. 1996; 117(3): 423-428.

101. Ryan MJ, Kavanagh R, Wall PG, Hazleman BL: Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol. 1997; 36(3): 370-373.

102. Li SF, Cassidy C, Chang C, Gharib S, Torres J: Diagnostic utility of laboratory tests in septic arthritis. Emerg Med J. 2007; 24(2): 75-77.

103. Li SF, Henderson J, Dickman E, Darzynkiewicz R: Laboratory tests in adults with monoarticular arthritis: can they rule out a septic joint? Acad Emerg Med. 2004; 11(3): 276-280.

104. Margaretten ME, Kohlwes J, Moore D, Bent S: Does this adult patient have septic arthritis? JAMA. 2007; 297(13): 1478-1488.

105. Parvizi J, Jacovides C, Zmistowski B, Jung KA: Definition of periprosthetic joint infection: is there a consensus? Clin Orthop Relat Res. 2011; 469(11): 3022-3030.

106. Spangehl MJ, Masri BA, O’Connell JX, Duncan CP: Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999; 81(5): 672-683.

107. Atkins BL, Athanasou N, Deeks JJ, et al: Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol. 1998; 36(10): 2932-2939.